Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NasdaqGS:IDXX
IDEXX Laboratories
|
543.45 | -1,93% | 11,41% | 44.882,08 | 0% | 18,75% |
|
NYSE:IQV
IQVIA Holdings
|
231.18 | 17,25% | 34,12% | 42.121 | 0% | 12,94% |
|
NasdaqGS:ICLR
ICON Public
|
314.72 | 8,72% | 23,9% | 26.022,25 | 0% | 16% |
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20.200,62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64,8% | 124,4% | 131.830,48 | 0% | 22,71% |
|
XTRA:SRT3
Sartorius
|
268.50 | 29,39% | 60,08% | 16.669,07 | 0,27% | 14,01% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.59 | -11,18% | -1,66% | 17.751,4 | 1,35% | 4,24% |
|
SWX:SGSN
SGS
|
80.72 | 887,92% | 968,45% | 15.278,36 | 3,95% | -1,74% |
|
NYSE:DGX
Quest Diagnostics
|
144.34 | -10,75% | -2,08% | 16.034,96 | 2,11% | 6,66% |
|
ENXTPA:BVI
Bureau Veritas
|
27.52 | 4,59% | 15,11% | 12.884,95 | 3,01% | 5,76% |
|
NasdaqGS:MEDP
Medpace Holdings
|
393.30 | -18,97% | -3,47% | 12.340,6 | 0% | 25,99% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29,25% | 11.046,73 | 0,84% | 7,46% |
|
NYSE:CRL
Charles River Laboratories International
|
221.61 | 15,62% | 31,45% | 11.815,07 | 0% | 12,09% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18,28% | 30,99% | 10.363,08 | 2,36% | 10,99% |
|
LSE:ITRK
Intertek Group
|
49.54 | 5.998,22% | 6.510,77% | 8.150,85 | 2,26% | 2,41% |
|
NYSE:CTLT
Catalent
|
55.37 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
ASX:SHL
Sonic Healthcare
|
26.63 | 6,42% | 29,07% | 12.778,75 | 3,85% | 5,68% |
|
SWX:BANB
Bachem Holding
|
90.60 | -6,38% | 15,44% | 6.252,8 | 0,87% | -15,25% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38.517,01 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25,31% | 38,17% | 4.424,39 | 2,87% | 10,04% |
